BACKGROUND: Ventral tegmental area (VTA) brain-derived neurotrophic factor (BDNF) contributes to time-dependent increases in cue-induced cocaine seeking after withdrawal (incubation of cocaine craving). Here, we studied the role of glial cell line-derived neurotrophic factor (GDNF) in incubation of cocaine craving because, like BDNF, GDNF provides trophic support to midbrain dopamine neurons. METHODS: We first trained rats to self-administer intravenous cocaine for 10 days (6 hours/d, cocaine injections were paired with a tone-light cue). We then manipulated VTA GDNF function and assessed cue-induced cocaine seeking in extinction tests after withdrawal from cocaine. RESULTS: VTA injections of an adeno-associated virus (AAV) vector containing rat GDNF cDNA (5 x 10(8) viral genomes) on withdrawal Day 1 increased cue-induced cocaine seeking on withdrawal days 11 and 31; this effect was not observed after VTA injections of an AAV viral vector containing red fluorescent protein (RFP). Additionally, VTA, but not substantial nigra (SN), GDNF injections (1.25 microg or 12.5 microg/side) immediately after the last cocaine self-administration session increased cue-induced drug seeking on withdrawal days 3 and 10; this effect was reversed by VTA injections of U0126, which inhibits the activity of extracellular signal-regulated kinases (ERK). Finally, interfering with VTA GDNF function by chronic delivery of anti-GDNF monoclonal neutralizing antibodies via minipumps (600 ng/side/d) during withdrawal Days 1-14 prevented the time-dependent increases in cue-induced cocaine seeking on withdrawal days 11 and 31. CONCLUSIONS: Our results indicate that during the first weeks of withdrawal from cocaine self-administration, GDNF-dependent neuroadaptations in midbrain VTA neurons play an important role in the development of incubation of cocaine craving.
BACKGROUND: Ventral tegmental area (VTA) brain-derived neurotrophic factor (BDNF) contributes to time-dependent increases in cue-induced cocaine seeking after withdrawal (incubation of cocaine craving). Here, we studied the role of glial cell line-derived neurotrophic factor (GDNF) in incubation of cocaine craving because, like BDNF, GDNF provides trophic support to midbrain dopamine neurons. METHODS: We first trained rats to self-administer intravenous cocaine for 10 days (6 hours/d, cocaine injections were paired with a tone-light cue). We then manipulated VTA GDNF function and assessed cue-induced cocaine seeking in extinction tests after withdrawal from cocaine. RESULTS: VTA injections of an adeno-associated virus (AAV) vector containing ratGDNF cDNA (5 x 10(8) viral genomes) on withdrawal Day 1 increased cue-induced cocaine seeking on withdrawal days 11 and 31; this effect was not observed after VTA injections of an AAV viral vector containing red fluorescent protein (RFP). Additionally, VTA, but not substantial nigra (SN), GDNF injections (1.25 microg or 12.5 microg/side) immediately after the last cocaine self-administration session increased cue-induced drug seeking on withdrawal days 3 and 10; this effect was reversed by VTA injections of U0126, which inhibits the activity of extracellular signal-regulated kinases (ERK). Finally, interfering with VTA GDNF function by chronic delivery of anti-GDNF monoclonal neutralizing antibodies via minipumps (600 ng/side/d) during withdrawal Days 1-14 prevented the time-dependent increases in cue-induced cocaine seeking on withdrawal days 11 and 31. CONCLUSIONS: Our results indicate that during the first weeks of withdrawal from cocaine self-administration, GDNF-dependent neuroadaptations in midbrain VTA neurons play an important role in the development of incubation of cocaine craving.
Authors: C J Messer; A J Eisch; W A Carlezon; K Whisler; L Shen; D H Wolf; H Westphal; F Collins; D S Russell; E J Nestler Journal: Neuron Date: 2000-04 Impact factor: 17.173
Authors: Dao-Yao He; Nancy N H McGough; Ajay Ravindranathan; Jerome Jeanblanc; Marian L Logrip; Khanhky Phamluong; Patricia H Janak; Dorit Ron Journal: J Neurosci Date: 2005-01-19 Impact factor: 6.167
Authors: Lin Lu; Bruce T Hope; Jack Dempsey; Shirley Y Liu; Jennifer M Bossert; Yavin Shaham Journal: Nat Neurosci Date: 2005-01-16 Impact factor: 24.884
Authors: T Green-Sadan; Y Kuttner; T Lublin-Tennenbaum; N Kinor; Y Boguslavsky; S Margel; G Yadid Journal: Exp Neurol Date: 2005-07 Impact factor: 5.330
Authors: Serge H Ahmed; Robert Lutjens; Lena D van der Stap; Dusan Lekic; Vincenzo Romano-Spica; Marisela Morales; George F Koob; Vez Repunte-Canonigo; Pietro Paolo Sanna Journal: Proc Natl Acad Sci U S A Date: 2005-08-02 Impact factor: 11.205
Authors: Jun Wang; Sebastien Carnicella; Somayeh Ahmadiantehrani; Dao-Yao He; Segev Barak; Viktor Kharazia; Sami Ben Hamida; Agustin Zapata; Toni S Shippenberg; Dorit Ron Journal: J Neurosci Date: 2010-10-27 Impact factor: 6.167
Authors: Mikko Airavaara; Charles L Pickens; Anna L Stern; Kristina A Wihbey; Brandon K Harvey; Jennifer M Bossert; Qing-Rong Liu; Barry J Hoffer; Yavin Shaham Journal: Addict Biol Date: 2010-12-23 Impact factor: 4.280
Authors: Lyonna F Alcantara; Brandon L Warren; Eric M Parise; Sergio D Iñiguez; Carlos A Bolaños-Guzmán Journal: Psychopharmacology (Berl) Date: 2014-01-23 Impact factor: 4.530
Authors: Russell W Brown; Seth L Kirby; Adam R Denton; John M Dose; Elizabeth D Cummins; Wesley Drew Gill; Katherine C Burgess Journal: Schizophr Res Date: 2017-03-14 Impact factor: 4.939
Authors: Florence R Theberge; Xuan Li; Sarita Kambhampati; Charles L Pickens; Robyn St Laurent; Jennifer M Bossert; Michael H Baumann; Mark R Hutchinson; Kenner C Rice; Linda R Watkins; Yavin Shaham Journal: Biol Psychiatry Date: 2013-02-04 Impact factor: 13.382
Authors: Xuan Li; M R DeJoseph; Janice H Urban; Amine Bahi; Jean-Luc Dreyer; Gloria E Meredith; Kerstin A Ford; Carrie R Ferrario; Jessica A Loweth; Marina E Wolf Journal: J Neurosci Date: 2013-01-16 Impact factor: 6.167
Authors: Sheketha R Hauser; Gerald A Deehan; Christopher P Knight; Jamie E Toalston; William J McBride; Zachary A Rodd Journal: Alcohol Clin Exp Res Date: 2016-09-22 Impact factor: 3.455